Enhanced Cytotoxic Effects of Cold Plasma Deposition of Topotecan: A Novel Approach for Local Cancer Drug Delivery to Glioblastoma Cells
Cancers · 09.01.2025 · 17 (2) · 201
DOI: 10.3390/cancers17020201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 09.01.2025. Verfasst von Beatriz Pinheiro Lopes und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, Ireland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council under the Enterprise Partnership Scheme.
Abstract (Originalsprache)
Background/Objectives: Despite the numerous advances in glioblastoma multiforme (GBM) treatment, GBM remains as the most malignant and aggressive form of brain cancer, characterized by a very poor outcome, highlighting the ongoing need for the development of new therapeutic strategies. A novel intervention using plasma-assisted local delivery of oncology drugs was developed to mediate the drug delivery, which might improve drug uptake and/or chemotherapeutic action. Topotecan (TPT), a water-soluble topoisomerase I inhibitor with major cytotoxic effects during the S-phase of the cell cycle, was selected as the candidate drug because despite its potent antitumor activity, the systemic administration to the brain is limited due to low crossing of the blood-brain barrier. For these reasons, TPT may be repurposed for local combined therapies.
Methods
We aimed to explore options for the local treatment of GBM where systematic delivery is challenging, using a combination between plasma-based technologies and TPT on a human brain cancer cell line (U-251mg).
Results
The evaluation of direct TPT plasma deposition using a helium plasma jet (J-Plasma, Apyx Medical) with a nebulizer onto U-251mg cells grown in 2D or 3D culture showed a reduction in the metabolic activity and cell mass and decreased long-term survival, indicating synergistic effects between the drug and the plasma treatment. The plasma-assisted approach was confirmed using temozolomide (TMZ) as a standard drug for glioblastoma treatment, as well as with two skin cancer cell lines.
Conclusions
These results revealed a pathway for new combinations and approaches to local drug application for a range of cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemical and Bioprocess Engineering, University College Dublin, D04 V1W8 Dublin, Ireland.
- Sustainability and Health Research Hub and School of Food Science and Environmental Health, Technological University Dublin, D07 H6K8 Dublin, Ireland.
- TheraDep Ltd., QUESTUM Innovation Centre, E91 V329 Clonmel, Ireland.
- Plasma Research Group, School of Biosystems and Food Engineering, University College Dublin, D04 V1W8 Dublin, Ireland.
- Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.
ORCID-Profile: Liam O'Neill, Paula Bourke
Förderung
- Irish Research Council under the Enterprise Partnership Scheme
Zitieren
APA
Pinheiro Lopes, B., O'Neill, L., Bourke, P., & Boehm, D. (2025). Enhanced Cytotoxic Effects of Cold Plasma Deposition of Topotecan: A Novel Approach for Local Cancer Drug Delivery to Glioblastoma Cells. Cancers, 17(2), 201. https://doi.org/10.3390/cancers17020201
Vancouver
Pinheiro Lopes B, O'Neill L, Bourke P, Boehm D. Enhanced Cytotoxic Effects of Cold Plasma Deposition of Topotecan: A Novel Approach for Local Cancer Drug Delivery to Glioblastoma Cells. Cancers. 2025;17(2):201. doi:10.3390/cancers17020201
BibTeX
@article{PinheiroLopes2025,
author = {Pinheiro Lopes, Beatriz and O'Neill, Liam and Bourke, Paula and Boehm, Daniela},
title = {Enhanced Cytotoxic Effects of Cold Plasma Deposition of Topotecan: A Novel Approach for Local Cancer Drug Delivery to Glioblastoma Cells},
journal = {Cancers},
year = {2025},
volume = {17},
number = {2},
pages = {201},
doi = {10.3390/cancers17020201}
}
EUVIMED